Phase I trial of interferon alpha2b and liposome-encapsulated all-trans retinoic acid in the treatment of patients with advanced renal cell carcinoma.

Jonathan S Goldberg; Manuel Vargas; Alyssa S Rosmarin; Matthew I Milowsky; Nicholas Papanicoloau; Lorraine J Gudas; Gary Shelton; Kevie Feit; Daniel Petrylak; David M Nanus

doi:10.1002/cncr.10809

Phase I trial of interferon alpha2b and liposome-encapsulated all-trans retinoic acid in the treatment of patients with advanced renal cell carcinoma.

Identifier:nobleid.org/w1/20260515/9C01D8D7

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/9C01D8D7.svg?ark=w1%2F20260515%2F9C01D8D7)](https://nobleid.org/work/w1/20260515/9C01D8D7)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Nicholas Papanicoloau

Claim authorship of this work

Phase I trial of interferon alpha2b and liposome-encapsulated all-trans retinoic acid in the treatment of patients with advanced renal cell carcinoma.

Identifier:nobleid.org/w1/20260515/9C01D8D7

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/9C01D8D7.svg?ark=w1%2F20260515%2F9C01D8D7)](https://nobleid.org/work/w1/20260515/9C01D8D7)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Nicholas Papanicoloau

Claim authorship of this work